Literature DB >> 26299922

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.

He-da Zhang1, Da-Wei Sun2, Ling Mao3, Jun Zhang4, Lin-Hong Jiang5, Jian Li6, Ying Wu7, Hao Ji8, Wei Chen8, Jing Wang7, Rong Ma9, Hai-Xia Cao9, Jian-Zhong Wu9, Jin-Hai Tang10.   

Abstract

OBJECTIVES: MiRNA-139 is located at 11q13.4 and it has anti-oncogenic and antimetastatic activity in humans. However, its role in controlling apoptosis, invasion and metastasis and the development of chemosensitivity to docetaxel in breast cancer cells are not fully understood. The aim of this study was to research the biological function of miR-139-5p and the efficacy of chemosensitivity to docetaxel.
METHODS: MiR-139-5p expression in MCF-7, MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR; cell viability was analyzed by Cell Counting Kit-8 assay; apoptosis and cell cycle were analyzed by flow cytometry; control of metastasis and invasion of breast cancer cells was measured by transwell assay; expression of Notch1 was measured by western blot; a luciferase reporter vector was constructed to identify the miR-139-5p target gene.
RESULTS: MiR-139-5p was significantly down-regulated in breast cancer cells. MiR-139-5p inhibits the viability of breast cancer cells. MiR-139-5p induces apoptosis, causes cell cycle arrest in S phase, inhibits migration and invasion in breast cancer cells, however, MiR-139-5p play the opposite role in docetaxel-induced breast cancer cells.
CONCLUSIONS: MiR-139-5p not only attenuated the development of breast cancer cells but also mediated drug-resistance by regulating the expression of the downstream target gene Notch1.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Chemoresistance; Notch1; miRNA 139-5p

Mesh:

Substances:

Year:  2015        PMID: 26299922     DOI: 10.1016/j.bbrc.2015.08.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.

Authors:  Zhengqiang Wang; Qianshan Ding; Yanxia Li; Qingqing Liu; Wei Wu; Lu Wu; Honggang Yu
Journal:  Tumour Biol       Date:  2016-09-16

2.  A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells.

Authors:  Maxine Umeh-Garcia; Catalina Simion; Pui-Yan Ho; Neelu Batra; Anastasia L Berg; Kermit L Carraway; Aiming Yu; Colleen Sweeney
Journal:  Cancer Res       Date:  2019-11-06       Impact factor: 12.701

3.  In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders.

Authors:  Jagmohan Singh; Ipsita Mohanty; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-10-19       Impact factor: 4.052

4.  Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.

Authors:  Marta Geretto; Alessandra Pulliero; Camillo Rosano; Dinara Zhabayeva; Rakhmet Bersimbaev; Alberto Izzotti
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

Review 5.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

6.  MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.

Authors:  Chaoying Yang; Zhaoxia Xia; Lifei Zhu; Yanchang Li; Zhixin Zheng; Jianying Liang; Liangcai Wu
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

7.  MicroRNA-139 inhibits the proliferation, migration and invasion of gastric cancer cells by directly targeting ρ-associated protein kinase 1.

Authors:  Xuechun Yu; Chaojian Ma; Ling Fu; Jingwu Dong; Jie Ying
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

8.  MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.

Authors:  Jianan Chen; Yan Yu; Xiaolong Chen; Yuting He; Qiuyue Hu; Hongqiang Li; Qicai Han; Fang Ren; Juan Li; Chao Li; Jie Bao; Zhigang Ren; Zhenfeng Duan; Guangying Cui; Ranran Sun
Journal:  Cell Prolif       Date:  2018-08-13       Impact factor: 6.831

Review 9.  Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

Authors:  Nina Petrović; Irina Nakashidze; Milica Nedeljković
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-21       Impact factor: 2.673

10.  MiR-139 Modulates Cancer Stem Cell Function of Human Breast Cancer through Targeting CXCR4.

Authors:  Chun-Wen Cheng; Wen-Ling Liao; Po-Ming Chen; Jyh-Cherng Yu; Hui-Ping Shiau; Yi-Hsien Hsieh; Huei-Jane Lee; Yu-Chun Cheng; Pei-Ei Wu; Chen-Yang Shen
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.